LYPD3

LYPD3 Informations sur la molécule

Nom anglais	Ly6/PLAUR domain-containing protein 3	Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	1	Alias de la cible	C4.4A，GPI-Anchored Metastasis-Associated Protein Homolog，2310061G07Rik，GPI-Anchored Metastasis-Associated Protein C4.4A Homolog，MIG-C4，UNQ491/PRO1007，Ly6/PLAUR domain-containing protein 3，LYPD3，Matrigel-Induced Gene C4 Protein，LY6/PLAUR Domain Containing 3
Phase de R&D la plus avancée	Phase 1 Clinical

Nom anglais	Ly6/PLAUR domain-containing protein 3
Alias de la cible	C4.4A，GPI-Anchored Metastasis-Associated Protein Homolog，2310061G07Rik，GPI-Anchored Metastasis-Associated Protein C4.4A Homolog，MIG-C4，UNQ491/PRO1007，Ly6/PLAUR domain-containing protein 3，LYPD3，Matrigel-Induced Gene C4 Protein，LY6/PLAUR Domain Containing 3
Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	1
Phase de R&D la plus avancée	Phase 1 Clinical

LYPD3 Liste de produits

Attribut
Protein (1)
Bibliothèque de produits
En ligne (1)
Espèces
Human (1)
Étiquette
His Tag (1)
Marqueur
Unconjugated (1)

Numéro de produit	Espèces	Système d'expression	Description du produit	Structure protéique	Pureté	Caractéristiques	Pré-commande/Commande
LY3-H52H5	Human	HEK293	Human LYPD3 / C4.4A Protein, His Tag				Ajouter au panier

Quantité totale1

LYPD3Contexte de la molécule

Ly6/PLAUR domain-containing protein 3 (LYPD3) is also known as MIG-C4 ,C4.4A, GPI-anchored metastasis-associated protein C4.4A homolog and Matrigel-induced gene C4 protein,which is a cell membrane protein containing two UPAR/Ly6 domains. LYPD3 is expressed in placenta, skin and urothelium. LYPD3 is found in the majority of primary and metastatic transitional cell carcinomas (TCCs) and as well in breast cancer tissues, but not in adjacent normal tissues. LYPD3 play a role in supporting cell migration and it is not only probably involved in urothelial cell-matrix interactions, but also in tumor progression.